Metastatic Breast Cancer
Metastatic breast cancer is considered an incurable disease although survival has improved in recent years with the advent of newer systemic therapies. Five-year survival is typically quoted as 26%. After a thorough workup including full-body imaging and biopsy of suspected metastatic sites, the patient should be initiated on systemic therapy. Local treatments including surgery and radiation are reserved for palliative purposes. Patients may progress through several lines of therapy. Involvement of palliative care and hospice teams in the multidisciplinary approach is key as is attention to quality of life issues.
KeywordsMetastatic Systemic therapy Palliation Quality of life
- 2.Surveillance, E.a.E.R.P. Cancer stat facts: female breast cancer. In: Cancer stat facts. National Cancer Institute Surveillance, Epidemiology and End Results Program (SEER). seer.cancer.gov. 1975–2014.Google Scholar
- 5.Network, N.C.C. NCCN- evidence blocks – recurrent or stage IV disease. In: NCCN guidelines version 2.2016 – invasive breast cancer. Fort Washington. www.nccn.org: National Comprehensive Cancer Network; 2016. p. 17–23.Google Scholar